CLINICAL_TRIALS
ClinicalTrials.gov record update
A Randomized, Open-label, Crossover Study to Assess the Comparative Pharmacokinetics, Bioequivalence, and Safety of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07421011
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:23.321377+00:00
- Published At
- 2026-02-19T00:00:00+00:00
- Record Updated At
- 2026-02-19
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Irritable Bowel Syndrome", "Gallstone Disease", "GERD", "Biliary Dyskinesia", "Postcholecystectomy Syndrome"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-19"- protocolSection.identificationModule.nctId
"NCT07421011"- protocolSection.identificationModule.officialTitle
"A Randomized, Open-label, Crossover Study to Assess the Comparative Pharmacokinetics, Bioequivalence, and Safety of Trimedat\u00ae 76,95 mg Orally Disintegrating Tablets and Trimedat\u00ae 100 mg Tablets in Healthy Volunteers."- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.